Equasym XL
Methylphenidate hydrochloride (modified-release)
Overview
Medication class
Equasym XL is the only methylphenidate MR product in the UK with a 30:70 IR:MR ratio. All other capsule brands use 50:50. This means Equasym XL provides a smaller initial effect and a larger, sustained second wave: a different shape of coverage across the day. For some patients this is exactly right; for others a different ratio works better. Because no other brand matches this profile, there is no direct substitute. MHRA guidance (September 2022) + SPS explicit note: Equasym XL should not be switched to or from any other methylphenidate MR product without specialist clinical review.
When it's prescribed
Prescribed for ADHD in children aged 6 and over and adults, per NICE NG87. Must be prescribed and dispensed by brand name (MHRA guidance, September 2022).
Typical duration
Up to 8 hours
Available strengths
10 mg, 20 mg, 30 mg. Maximum: 60 mg/day
Key advantages
- Lower first peak than 50:50 capsule brands: may suit people sensitive to the initial 'spike'
- Larger sustained second wave: prolonged effect in the afternoon
- Capsules can be opened and sprinkled: helpful if you struggle to swallow
- Not pH-dependent: compatible with PPIs and antacids
Key cautions
- Standalone brand: no safe alternative in case of supply disruption without specialist review
- Smaller range of strengths (10–30 mg) than some other brands
- 8-hour duration: may not cover a full working day for everyone
How it works
Methylphenidate blocks the brain's recycling transporters for dopamine and noradrenaline: keeping them available longer in the synapse. This helps the prefrontal cortex regulate attention, motivation, and impulse control.
Equasym XL capsules contain two types of pellets:
• Immediate-release pellets (30%): dissolve quickly; first onset within 1–2 hours • Modified-release pellets (70%): polymer-coated; second release approximately 4–5 hours later
The result is a smaller morning peak and a stronger, more sustained afternoon effect. This profile suits some people better than 50:50 brands: less of an initial 'jolt' and more sustained afternoon coverage.
Equasym XL is not pH-dependent; it is compatible with PPIs and antacids.
How to take it
When to take it
Once in the morning. Up to 8 hours' duration: take before 9am to avoid it being active at bedtime.
With or without food
Either is fine: Equasym XL does not require food.
Swallowing options
Option 1: Swallow the capsule whole with water. Option 2: Open the capsule and sprinkle pellets onto a small cold spoonful of soft food (yoghurt, applesauce). Eat immediately. Cold food only. Do not save for later. Do not crush or chew the pellets; this destroys the modified-release coating.
Missed dose
If still morning, take as soon as you remember. If mid-afternoon, skip it: never double up.
Alcohol
Avoid entirely. Risk of dose-dumping and ethylphenidate formation: see the MPH MR landing page for full explanation.
What to expect: week by week
Adjustment
Appetite dips; mild headache (usually dehydration: drink more water); possibly feeling more alert. Most settle by week 2.
Settling in
Most early side effects reduce. The 30:70 profile means the main effect builds through the morning: some people describe a gentler start with a more sustained afternoon effect compared to 50:50 brands.
Optimising
Working towards the ideal dose. Available strengths (10–30 mg) mean dose adjustment steps are in 10 mg increments.
Maintenance
Reviews every 6 months. BP, HR, and weight checked at each visit.
Side effects & what helps
All expanded by default: tap a category to collapse it. Most of these ease in the first 1–2 weeks.
Reduced appetite; weight loss (long-term)
Very commonWhat helps
Appetite usually returns in the evening. Monitored at every review.
Difficulty sleeping if taken late
Very commonWhat helps
Take before 9am. Discuss with prescriber if still disrupted at 4 weeks.
Increased HR and BP; palpitations
CommonWhat helps
Monitored at every review. Contact prescriber if resting HR consistently above 100 bpm.
Anxiety, irritability, low mood
CommonWhat helps
Tell your prescriber if persistent.
Suicidal thoughts
UncommonWhat helps
Contact prescriber or crisis support immediately.
Psychosis symptoms; mania
Uncommon/RareWhat helps
Stop and seek urgent review.
Headache
Very commonWhat helps
Usually settles by week 2. Drink more water.
Dizziness, tremor
CommonWhat helps
Usually settles in the first few weeks.
Tics
RareWhat helps
Contact your prescriber.
Nausea, dry mouth, sweating, hair thinning, teeth grinding
CommonWhat helps
Mention at your next review if troublesome.
Priapism (painful erection more than 2 hours)
Rare: medical emergencyWhat helps
Attend A&E immediately.
When to seek help
Expected: mention at next review
Common in the first few weeks: no action usually needed
- Mild appetite reduction
- Mild headache weeks 1–2
- Dry mouth
- Mild sleep difficulty
- Mild irritability improving
Contact your prescriber within a few days
Not urgent: but worth discussing at your next review
- Resting HR >100 bpm
- BP persistently raised
- Headaches beyond 2 weeks
- Mood not settling at 4 weeks
- Sleep severely disrupted beyond 4 weeks
- Significant weight loss
- Tics
- Blurred vision; Raynaud's
Contact prescriber or 111 today
Do not wait for a routine appointment
- Resting HR >120 bpm
- Fainting
- Suicidal thoughts
- Hallucinations/psychosis
- Priapism
- Severe allergic reaction
- New mania
What you can safely try while waiting for a review
Frequently asked questions
Can I switch to a different brand if Equasym XL is out of stock?
Only with specialist input. Equasym XL has no bioequivalent brand: the 30:70 IR:MR profile is unique. Switching to a 50:50 capsule (e.g. Ritalin XL) or a 12-hour tablet brand changes the shape of your day significantly. This needs clinical review and dose reassessment, not a straight swap. Contact your prescriber before accepting a different brand.
Can I sprinkle the capsule on food?
Yes: onto cold soft food (yoghurt, applesauce) only. Eat immediately. Do not save for later. Do not crush or chew the pellets.
Does it interact with omeprazole or antacids?
No: Equasym XL is not pH-dependent. It can be taken alongside PPIs, H2-blockers, and antacids without issue.
Why is the first effect less noticeable than with other brands?
Equasym XL releases only 30% of its dose immediately: the rest comes 4–5 hours later. So the first onset may feel more gradual than 50:50 brands. This is by design; it suits people who find the first peak of 50:50 brands too sharp. If you need a stronger morning effect, discuss this with your prescriber.
I'm pregnant or breastfeeding: what do I need to know?
Pregnancy: Speak to your prescriber before making any changes (BUMPS/UKTIS January 2023). Do not stop without advice. Breastfeeding: Methylphenidate is the stimulant of choice during breastfeeding (BfN April 2025). Very low milk levels. No need to stop breastfeeding. Monitor baby for irritability, sleep changes, or feeding difficulties.
Ask your prescriber
Questions worth raising at your next review. You don't need to cover all of them: pick the ones that feel most relevant.
- Why Equasym XL for me: what was the reasoning behind the 30:70 release profile?
- What if my pharmacy can't get Equasym XL: I've heard I can't just switch brands?
- The morning effect seems gentler than I expected: is that normal for this brand?
- What dose are we starting at, and what is the maximum?
- If Equasym XL doesn't work well enough, what options are there given I can't switch brands directly?
For GPs & clinicians
Equasym XL (Takeda): biphasic capsule; 30:70 IR:MR ratio; second peak ~4–5h; duration 8h. Not pH-dependent. No food requirement.
No other MR product is bioequivalent to Equasym XL. Do not switch to or from Equasym XL without specialist review. This is an SPS-specific caution: more restrictive than for other capsule brands. If Equasym XL is unavailable, contact the specialist before prescribing an alternative.
Not formally licensed for adults (BNF). Used under specialist direction per NICE NG87. BP and HR at baseline, dose changes, minimum every 6 months.
MAOIs (contraindicated); alcohol (ethylphenidate formation, dose-dumping); antihypertensives (reduced efficacy); coumarin anticoagulants (monitor INR).
This guide is written for educational purposes and does not constitute medical advice. Always follow the guidance of your prescriber or pharmacist. If you have concerns about your medication, contact your clinical team.